Volpe's Neurology of the Newborn, Seventh Edition 2024
Download
EDITOR-IN-CHIEF
JOSEPH J. VOLPE, MD
Neurologist-in-Chief Emeritus
Department of Neurology
Boston Children’s Hospital
Bronson Crothers Distinguished Professor of
Neurology
Harvard Medical School
Boston, Massachusetts
Lead Associate Editor
TERRIE E. INDER, MBCHB, MD
Director, Center for Neonatal Research
Department of Pediatrics
Children’s Hospital of Orange County
Orange, California
Professor
Department of Pediatrics
University of California Irvine
Irvine
California
LINDA S. DE VRIES, MD, PHD
Department of Neonatology
University Medical Center
Utrecht
The Netherlands
Leiden
University Medical Center
LeidenThe Netherland
DONNA M. FERRIERO, MD, MS
Distinguished Professor
Department of Neurology and Pediatrics
University of California
San Francisco, California
Associate Editors
BASIL T. DARRAS, MD
Associate Neurologist-in-Chief
Department of Neurology
Boston Children´s Hospital
Joseph J. Volpe Professor of Neurology
Department of Neurology
Harvard Medical School
Boston, Massachusetts
ADRÉ J. DU PLESSIS,
MBCHB, MPH
Director, Prenatal Pediatrics Institute
Chief, Division of Prenatal and
Transitional
Pediatrics
Children´s National Hospital
Washington, DC
JEFFREY M. PERLMAN, MBCHB
Professor
Department of Pediatrics
Weill Cornell Medicine
Attending Neonatologist
New York Presbyterian Hospital
New York, New York
Pages: 1775
- Language: English
- Format: PDF
- Size : 78.0 MB
- Contents :
- . UNIT I: HUMAN BRAIN DEVELOPMENT
- . UNIT II: FETAL NEUROLOGY
- . UNIT III: NEUROLOGICAL EVALUATION
- . UNIT IV: SEIZURES
- . UNIT V: HYPOXIC-ISCHEMIC AND RELATED
DISORDERS
. UNIT VI: INTRACRANIAL HEMORRHAGE
. UNIT VII: METABOLIC ENCEPHALOPATHIES
. UNIT VIII: DEGENERATIVE DISORDERS
. UNIT IX: NEUROMUSCULAR DISORDERS
. UNIT X: INTRACRANIAL INFECTIONS
. UNIT XI: PERINATAL TRAUMA
. UNIT XII: INTRACRANIAL MASS LESIONS
. UNIT XIII: DRUGS AND THE DEVELOPING
NERVOUS SYSTEM
. UNIT XIV: NEUROLOGY IN LOW
RESOURCE SETTINGS
PREFACE
The 40 years since the publication of the first edition of this
book have witnessed a remarkable evolution of the discipline
of the neurology of the newborn. In 1981, when the first edition was published, in the preface I expressed a sense of a
“new frontier” to be pioneered. Currently, articles on neonatal
neurology are abundant in the major clinical journals in the
fields of pediatrics, neurology, neonatology, perinatology, and
obstetrics, among others, and in multiple scientific journals of
the many neurobiological disciplines. Moreover, annual meetings of scientific societies in these fields are replete with clinical studies and clinical and basic research on the neurology
of the newborn. Thus venturing into the new frontier sensed
in 1981 has led to an extraordinarily exciting discipline and,
perhaps most importantly, to the promise of effective interventions to prevent or ameliorate neurological disability in
our neonatal patients .
As with previous editions, this book is intended for a
broad audience, from the most highly specialized neonatal
physicians to those with a broader, more general perspective.
This breadth of focus creates challenges in writing. We have
avoided presenting a compendium of disembodied facts and,
rather, have attempted to create a scaffold of principles upon
which the ever-expanding corpus of relevant information is
added. A particular effort has been exerted to bring the latest
science into the clinical setting, with a special emphasis on
translating new knowledge to the infant’s bedside .
To facilitate the fundamental messaging throughout the
book, we have made liberal use of tables and boxes to synthesize major points. The great illustrative value of figures, in
the form of flow diagrams, key experimental findings, clinical
and pathological specimens, and all types of state-of-the-art
neuroimaging, is emphasized in every chapter. Approximately
1000 figures are presented in this edition.
The explosion of new knowledge from the study of the
newborn is reflected in the citation of more than 17,000 references. Although they are numbered consecutively in the text,
the reference list in the print edition contains only the most
recent citations, but all are contained in the list in the online
edition .
The organization of the book is similar to that of the sixth
edition, but with an addition of five chapters, for a total of
43. The chapters are presented in 14 units. Unit I contains
eight chapters that address human brain development and the
disorders that present when this development is disturbed.
Molecular genetics, advanced imaging, and modern-day neuropathological and neuroembryological studies have greatly
advanced this area. Unit II, new to this edition, contains three
chapters that address fetal neurology and illustrate the importance of understanding and investigating the maternal-fetal origins of neonatal disease. The third unit, concerning
the neurological evaluation, describes new methodologies
to study the newborn brain, including advanced magnetic
resonance imaging (MRI) techniques. A new chapter on neurodevelopmental follow-up has been added to this unit.
The fourth unit focuses entirely on neonatal seizures and has
been expanded significantly. This unit serves as an effective
bridge to the subsequent disease-focused units .
Unit V, the largest in the book, consists of 10 chapters and
addresses the critical area of hypoxic-ischemic and related
disorders, especially those involving systemic/neuroinflammation. Each of these chapters has been updated and revised
accordingly. A new chapter on inflammation has been added
to this unit. Unit VI addresses intracranial hemorrhage and
involves three chapters. Major advances in the study of intraventricular hemorrhage, posthemorrhagic hydrocephalus,
cerebellar hemorrhage, and new MRI-delineated lesions
(for example, subpial hemorrhage) are emphasized. Unit VII
addresses metabolic encephalopathies, involving particularly
glucose, bilirubin, and amino acid and organic acid metabolism. New insights into molecular genetics, pathogenetic
mechanisms, and management are highlighted. Unit VIII comprises a single chapter on degenerative disorders. Emphasis is
placed on major insights provided by molecular genetics and
advances in therapies. Unit IX addresses neuromuscular disorders. The four chapters in this unit are notably comprehensive and emphasize recent advances in diagnosis by molecular
genetics and in treatment. Unit X on intracranial infections
includes chapters on viral, protozoan, and related intracranial
infections and on bacterial and fungal infections. These two
chapters have been greatly expanded. Unit XI focuses on perinatal trauma and a wide variety of injuries involving intracranial structures, the spinal cord, and peripheral nerves.
Unit XII addresses intracranial mass lesions, especially
brain tumors and vein of Galen malformations. Especially
emphasized are new insights into molecular characterization
of brain tumors and the relation of this characterization to
management and outcomes. Advances in diagnosis and management of vein of Galen malformations are presented. Unit
XIII is a single chapter on drugs and the developing nervous
system. Recent insights into the spectrum of drugs involved,
the related prenatal and postnatal syndromes, and optimal
management are described in this appreciably expanded
chapter. The final unit contains a new chapter that illustrates
the disappointing gap in resources available in low-resource
settings and the resulting adverse effects on incidence of injuries and outcomes .
I am privileged to be joined by a distinguished group of
authors, most of whom are longtime colleagues. Among them
are co-editor Terrie Inder and associate editors Basil Darras,
Linda de Vries, Adré du Plessis, Donna Ferriero, and Jeffrey
Perlman, who are leaders in their respective fields. New to
this edition are Robin Haynes, Peter Anderson, Alistair Gunn,
Pierre Gressens, Michael Rivkin, Jane Harding, Jon Watchko,
Gerard Berry, and Mohamed El-Dib.
Terrie Inder, an active investigator and leader of a major
neonatology program at Children’s Hospital of Orange County (University of California Irvine), deserves particular
recognition. In addition to authoring or coauthoring multiple excellent chapters in this book, she provided invaluable
opinions and input on many other chapters. Additionally,
she interacted with Elsevier about many issues related to the
preparation of the book, many of which are far beyond my
rudimentary skills in digital technology.
We are all particularly indebted to Shaye Moore, leader of
the Medical Writing Team in the Department of Neurology
at Boston Children’s Hospital/Harvard Medical School. She
tolerated my need to write and edit in longhand and managed
thousands of references from multiple chapters and digital
libraries with great facility. No challenge was ever too difficult
for her to resolve. Additionally, my assistant for the past 30
years, Irene Miller, again typed and retyped multiple manuscripts and managed innumerable references with aplomb.
We are especially grateful to the Elsevier team, led by Sarah
Barth, who supported my pursuit of perfection with grace,
skill, and understanding. We thank also Kate Mannix, who
managed every detail required for generation of a superb final
product. The guidance, patience, and efficiency of the entire
group brought this very large project to fruition.